GMNN and cancer: This finding is consistent with previous immunohistochemical, immunoblotting and in situ hybridisation studies where geminin is overexpressed in cancer cell lines (Xouri et al, 2004) and unveiled as a proliferation marker in different human cancers (Wohlschlegel et al, 2002).